Comments Submitted to OPHS on Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care. (HHS-OPHS-2014-0005). Click here to read the comments.
FOR IMMEDIATE RELEASE: June 18, 2014 CONTACT: Jeremy Glunt + 1.703.258.3506 email@example.com Alexandria, VA – The Certified Clinical Research Associate (CCRA®) designation is now formally recognized by TransCelerate Biopharma, Inc. as evidence of Good Clinical Practice (GCP) training. Recognition of the CCRA® designation follows TransCelerate’s January 2014 recognition of the Certified Clinical Research […]